Organogenesis Holdings Inc. ORGOW 深 滬

Deckers Outdoor, UP Fintech And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures rise with Dow gaining 300 points. Deckers Outdoor Corp shares fall after beating Q4 revenue estimates and providing fiscal 2027 guidance.

05-22 20:38

Organogenesis Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY26 sales guidance below estimates.

Organogenesis Holdings shares are trading lower after the company reported wors...

05-08 19:59

What's Going On With Organogenesis Stock On Wednesday?

Organogenesis stock rises after PuraPly AM trial shows improved diabetic foot ulcer closure; RSI signals oversold levels amid weak trend.

04-08 22:15

Organogenesis Holdings Completes Type-B Meeting With FDA And Plans to File BLA For ReNu Before The End Of December

Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports

04-07 05:37

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

04-06 23:02

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

04-06 21:30

BTIG Reiterates Buy on Organogenesis Holdings, Maintains $8 Price Target

BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $8 price target.

03-26 17:43

Organogenesis Director Arthur S Leibowitz Acquires Common Shares

Organogenesis Director Arthur S Leibowitz Acquires Common Shares Arthur S. Leibowitz, a director of Organogenesis Holdings Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technolo

03-12 09:46

BTIG Maintains Buy on Organogenesis Holdings, Lowers Price Target to $8

BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and lowers the price target from $9 to $8.

02-27 18:35

Organogenesis Holdings Sees FY2026 Sales $350.000M-$420.000M vs $543.400M Est.

Organogenesis Holdings (NASDAQ:ORGO) sees FY2026 sales of $350.000 million-$420.000 million vs $543.400 million analyst estimate.

02-27 05:26